NR5A1 and breast cancer: We observed that ex vivo breast cancer metastatic progression is reduced in the lungs of ELP-/- mice relative to the wild-type control after 21 days (p < 0.05) (Figure 4), suggesting that selectins are important for lung metastasis of TN breast cancer and may serve as a potential therapeutic target.